Skip to main content
logo
Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
3.470
-0.180 (-4.93%)
Aug 20, 2026, 10:07 AM EDT - Market open

Rocket Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
3813801,3122,7021,4811,407
Market Cap Growth
15.75%-71.04%-51.45%82.43%5.29%-57.65%
Enterprise Value
1221821,1022,2901,1971,008
Last Close Price
3.653.5112.5729.9719.5721.83

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
1.081.372.835.493.033.09
P/TBV Ratio
1.321.783.296.313.493.32

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.070.090.060.050.050.05
Net Debt / Equity Ratio
-0.70-0.59-0.75-0.71-0.68-0.80
Net Debt / EBITDA Ratio
1.420.751.321.401.532.28
Net Debt / FCF Ratio
1.520.861.611.651.792.84
Quick Ratio
9.066.269.157.699.1017.54
Current Ratio
9.246.389.307.809.3017.69
Return on Equity (ROE)
-4.77%-60.27%-54.14%-50.01%-46.98%-35.29%
Return on Assets (ROA)
-28.42%-33.29%-31.21%-28.69%-26.68%-19.10%
Return on Capital Employed (ROCE)
-49.00%-76.10%-56.10%-49.60%-43.70%-35.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-4.31%-58.74%-19.73%-9.09%-14.98%-12.02%
FCF Yield
-42.53%-50.14%-16.43%-7.82%-12.59%-9.15%
Buyback Yield / Dilution
-8.61%-17.21%-12.85%-23.27%-7.77%-14.18%
SEC Filings: 10-K · 10-Q